Holders — by stockHoldings — by fund
Aisling Capital Management LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001766721
$471.6M
disclosed book value
14
positions
72.5%
largest position share
Positions, as of 2026-06-30
top 14 of 14 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | BBIOBRIDGEBIO PHARMA INC | 4.6M | $341.8M | 72.5% |
| 2 | GLUEMONTE ROSA THERAPEUTICS INC | 1.6M | $37.6M | 8% |
| 3 | SNDXSYNDAX PHARMACEUTICALS INC | 1.3M | $28.8M | 6.1% |
| 4 | CMPSCOMPASS PATHWAYS PLC | 1.4M | $20.3M | 4.3% |
| 5 | BCAXBICARA THERAPEUTICS INC | 568,919 | $16.9M | 3.6% |
| 6 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 1.0M | $7.8M | 1.6% |
| 7 | SRRKSCHOLAR ROCK HLDG CORP | 77,031 | $4.2M | 0.9% |
| 8 | UROGEN PHARMA LTD | 108,000 | $4.0M | 0.8% |
| 9 | BMEABIOMEA FUSION INC | 2.0M | $3.0M | 0.6% |
| 10 | ACRSACLARIS THERAPEUTICS INC | 434,455 | $2.3M | 0.5% |
| 11 | EPRXEUPRAXIA PHARMACEUTICALS INC | 325,000 | $2.1M | 0.5% |
| 12 | VTVTVTV THERAPEUTICS INC | 50,000 | $1.9M | 0.4% |
| 13 | MRKRMARKER THERAPEUTICS INC | 325,370 | $478,293 | 0.1% |
| 14 | OKURONKURE THERAPEUTICS INC | 88,607 | $404,048 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.